Kimberly Duncan
Family · Birmingham, ALNPI 1649840463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $919, 6.2 times the $149 reported in 2021.
Across 46 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$125
- Boehringer Ingelheim$120
- Pharmaessentia USA Corporation$89
- Incyte Corporation$74
- Beone Medicines USA, Inc.$73
- Novartis$73
- plus $562 from 20 others
What the payments were for
- Food & beverage$1,117100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $125 |
| Boehringer Ingelheim | 1 | $120 |
| Pharmaessentia USA Corporation | 3 | $89 |
| Incyte Corporation | 3 | $74 |
| Beone Medicines USA, Inc. | 4 | $73 |
| Novartis | 3 | $73 |
| Bristol Myers Squibb | 3 | $67 |
| Eisai Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $42 |
| Genmab U.S., Inc. | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Geron Corporation | 1 | $24 |
| Merck | 1 | $24 |
| Sobi, Inc | 1 | $22 |
| Coopersurgical, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $21 |
| AbbVie | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $17 |
| Fennec Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$1,117 in reported general payments places this provider in the 65th percentile of 3,415 family providers in Alabama.
Other family in Birmingham
- Kellyn McMahonBirmingham$39K
- Rachel MesserBirmingham$22K
- Juyong JacksonBirmingham$21K
- Abigail McCroryBirmingham$19K
- Danielle BlackardBirmingham$19K
- Leanne PeoplesBirmingham$17K
- Brandie WeidmanBirmingham$13K
- Alison PetersonBirmingham$13K
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.